PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
04-Oct-2023 Aerium Therapeutics Advances Next Generation Antibodies to Protect Immunocompromised Persons Against COVID-19 Businesswire
04-Oct-2023 DocGo Partners with Main Line Health in Philadelphia to Provide Medical Transportation, and Agrees to Collaborate on Remote Patient Monitoring Initiatives Businesswire
04-Oct-2023 MyMD Pharmaceuticals to Present Updated Statistically Significant Phase 2 Data for MYMD-1, Potential TNF-α Market Disrupter, at BioFuture 2023 Businesswire
04-Oct-2023 Cardurion Pharmaceuticals Welcomes Emma Reeve as Independent Board Director and Audit Chair Businesswire
04-Oct-2023 Phastar Net-Zero Target Approved by the Science Based Targets Initiative Phastar
04-Oct-2023 Shorla Oncology Secures $35M Series B Funding Round to Advance its Oncology Product Portfolio Businesswire
04-Oct-2023 ROME Expands Leadership Team with the Appointment of Industry Veteran Kyle Kuvalanka as Chief Financial Officer and Chief Business Officer Businesswire
04-Oct-2023 Bausch + Lomb Will Present New Scientific Data and Analyses at American Academy of Optometry Annual Meeting Businesswire
04-Oct-2023 Trinity Life Sciences Introduces Launch Accelerator 2.0, the First and Only Benchmark-Based Launch Tool for Pharma Trinity Life Sciences
04-Oct-2023 CTMC partners with ScaleReady to automate, close, and scale for greater patient accessibility ScaleReady
04-Oct-2023 PureTech Founded Entity Vedanta Biosciences Announces First Patient Dosed in Phase 2 Clinical Trial of VE202 for the Treatment of Ulcerative Colitis and Receives Fast Track Designation PureTech Health plc
04-Oct-2023 Foghorn Therapeutics to Present Clinical and Pre-Clinical Data from Multiple Programs Across Its Diverse Pipeline at AACR-NCI-EORTC International Conference Foghorn Therapeutics
04-Oct-2023 Myricx Expands its ADC Expertise with the Appointment of Francesca Zammarchi as CSO Myricx
04-Oct-2023 Rejuvenate Biomed announces positive results from Phase 1b clinical trial with RJx-01 in sarcopenia Rejuvenate Biomed NV
04-Oct-2023 Eurofins CDMO Alphora Inc. (Canada) Announces the Launch of its Biologics Initiative focusing on mAbs and Therapeutic Proteins Businesswire
04-Oct-2023 CellProthera completes enrollment in Phase I/IIB trial for post-myocardial infarction cell therapy CellProthera
04-Oct-2023 IO Biotech Announces Three Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting IO Biotech
04-Oct-2023 ViroCell expands business development team to support next phase of growth ViroCell
04-Oct-2023 Velocity opens three UK greenfield clinical research sites Velocity
04-Oct-2023 Novotech Appoints Dr. Judith Ng-Cashin as Chief Medical Officer to Drive Global Medical Services Novotech